XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Jul. 28, 2024
Jul. 30, 2023
Cash flows from operating activities:    
Net loss $ (7,261) $ (3,342)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 1,581 1,635
Non-cash inventory credit (268) (717)
Amortization 99 96
Stock-based compensation 176 322
Deferred income taxes 60 (86)
Gain sale of equipment (4) (270)
Non-cash restructuring expenses 1,643 237
Foreign currency exchange (loss) gain 45 (372)
Changes in assets and liabilities:    
Accounts receivable (445) 2,112
Inventories 3,458 1,792
Other current assets (221) (526)
Other assets 90 (134)
Accounts payable – trade 884 (2,353)
Deferred revenue 105 (166)
Accrued restructuring 640 10
Accrued expenses and deferred compensation (478) (2,311)
Income taxes (310) (362)
Net cash used in provided by operating activities (206) (4,435)
Cash flows from investing activities:    
Capital expenditures (501) (513)
Proceeds from the sale of equipment 37 294
Proceeds from note receivable 90 60
Proceeds from the sale of investments (rabbi trust) 229 780
Purchase of investments (rabbi trust) (187) (247)
Net cash (used in) provided by investing activities (332) 374
Cash flows from financing activities:    
Procceds from line credit - China 4,010  
Net cash provided by financing activities 4,010  
Effect of exchange rate changes on cash and cash equivalents (12) (91)
Increase (decrease) in cash and cash equivalents 3,460 (4,152)
Cash and cash equivalents at beginning of period 10,012 20,964
Cash and cash equivalents at end of period $ 13,472 $ 16,812